Inhibrx Biosciences, Inc. (INBX)
NASDAQ · Healthcare
Inhibrx Biosciences, Inc. Cash on Hand 2023–2025
Inhibrx Biosciences, Inc. annual cash on hand history from 2023 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Inhibrx Biosciences, Inc. cash on hand as of December 31, 2025: 124.2M, a 18.60% decrease year-over-year.
- Inhibrx Biosciences, Inc. cash on hand for 2025 were 124.2M, a 18.60% decrease from 2024.
- Inhibrx Biosciences, Inc. cash on hand for 2024 were 152.6M, a 45.09% decrease from 2023.
- Inhibrx Biosciences, Inc. cash on hand for 2023 were 277.9M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Inhibrx Biosciences, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $124 |
| 2024 | $153 |
| 2023 | $278 |
Inhibrx Biosciences, Inc. Cash on Hand — FAQ
Inhibrx Biosciences, Inc. (INBX) cash on hand over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INBX's cash on hand history?
The chart and table above show Inhibrx Biosciences, Inc.'s cash on hand by year and by quarter, including the growth rate.